Rumi Scientific

Rumi Scientific is a research-driven company focused on the discovery of drugs and innovative treatments for human genetic diseases affecting the central nervous system. We have created an exciting human organoid-based platform that can be used for agnostic drug discovery and can be translated at the level of high-throughput screening. We have unlocked the full potential of human organoid technology for the discovery of tomorrow’s therapeutics. Our platform harnesses the power of embryonic stem cells to model human development in vitro and combines accurate genetic models of human diseases introduced by gene editing together with multi-cellular self-organization to create defined pathological embryonic tissues that serve as a basis for drug screening using artificial intelligence. While we are pursuing an ongoing drug development effort for Huntington’s Disease, we are also expanding the company focus towards neurodevelopment disorders. We believe that focusing on synthetic human embryology in both normal and disease contexts will open new doors towards treatments for many genetic disorders that still have no cures.